secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2023-12-14T23:59:59+00:00
Accession:  0001213900-23-095741
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne Q4 product revenue $742K vs $69K YoY; net loss $3.1M; FDA clears OneRF Ablation System
--------------------------------------------------------------------------------

- Product revenue $742K (Q4) vs $69K YoY; full year $1.952M vs $171K.
- Net loss $3.1M (Q4) vs $1.4M; full year $11.9M vs $10.0M.
- Received FDA 510(k) clearance for OneRF Ablation System in Dec 2023; commercial launch expected H1 2024.
- Cash $5.3M as of Sep 30, 2023, down from $11.1M; raised $5.2M net in public offering and $2.5M via ATM at $1.77/share.
- Zimmer Biomet expanding Evo sEEG launch; device sales ramp expected quarter by quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390023095741/0001213900-23-095741-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390023095741/ea189916-8k_neuroone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-095741

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer